| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Di Donato, Stefano |
| dc.contributor.author | Smerilli, Gianluca |
| dc.contributor.author | Becciolini, Andrea |
| dc.contributor.author | Camarda, Federica |
| dc.contributor.author | Cauli, Alberto |
| dc.contributor.author | Cazenave, Tomas |
| dc.contributor.author | de agustin, Juan jose |
| dc.contributor.author | Michelena, Xabier |
| dc.date.accessioned | 2025-11-05T13:22:15Z |
| dc.date.available | 2025-11-05T13:22:15Z |
| dc.date.issued | 2025-10 |
| dc.identifier.citation | Di Donato S, Smerilli G, Becciolini A, Camarda F, Cauli A, Cazenave T, et al. Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study. Semin Arthritis Rheum. 2025 Oct;74:152823. |
| dc.identifier.issn | 0049-0172 |
| dc.identifier.uri | http://hdl.handle.net/11351/14023 |
| dc.description | Calcifications; Enthesitis; Enthesophytes |
| dc.description.abstract | Objectives: To explore the prevalence and distribution of ultrasound-detected lesions indicating structural damage at the enthesis (e.g., bone erosions, enthesophytes, and calcifications) in patients with spondyloarthritis (SpA), comparing those with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), and to investigate the demographic, clinical, and metabolic factors linked to these lesions.
Methods: A cross-sectional analysis was conducted using data from the DEUS study, a multicentre investigation involving 20 rheumatology centres and including 413 patients with SpA (224 with axSpA and 189 with PsA). All participants underwent standardized clinical and ultrasound assessment of the large lower limb entheses (quadriceps tendon, proximal and distal patellar tendons, Achilles tendon, and plantar fascia). Entheseal structural lesions were explored by ultrasound and classified according to OMERACT definitions. Bivariate analyses and multivariate logistic regression were used to assess associations between ultrasound lesions and SpA patients' characteristics.
Results: In SpA patients, enthesophytes were the most common lesion (78.7 %), followed by calcifications (43.6 %) and bone erosions (24.9 %). Enthesophytes were more prevalent in PsA (86.8 %) compared to axSpA (71.9 %) (p < 0.001), with no significant differences in erosions and calcifications. However, lesion distribution varied across different entheses. Multivariate analysis revealed that entheseal erosions were significantly associated with inflammatory markers, HLA-B27 positivity, clinical enthesitis, and longer disease duration. Enthesophytes were significantly linked to PsA, psoriasis, clinical enthesitis, and longer disease duration. Calcifications were positively associated with hypertension, metabolic syndrome, and obesity. All lesions were associated with biologic DMARD use.
Conclusions: This study reveals a high prevalence of ultrasound-detected structural damage at the enthesis and identifies distinct SpA phenotypes based on these findings. |
| dc.language.iso | eng |
| dc.publisher | Elsevier |
| dc.relation.ispartofseries | Seminars in Arthritis and Rheumatism;74 |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Fenotip |
| dc.subject | Ecografia |
| dc.subject | Espondiloartropaties |
| dc.subject | Artritis psoriàsica |
| dc.subject.mesh | Spondylarthritis |
| dc.subject.mesh | Ultrasonography |
| dc.subject.mesh | Arthritis, Psoriatic |
| dc.subject.mesh | Phenotype |
| dc.title | Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.semarthrit.2025.152823 |
| dc.subject.decs | espondiloartritis |
| dc.subject.decs | ecografía |
| dc.subject.decs | artritis psoriásica |
| dc.subject.decs | fenotipo |
| dc.relation.publishversion | https://doi.org/10.1016/j.semarthrit.2025.152823 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Di Donato S] Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK. [Smerilli G] Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Polytechnic University of Marche, Ancona, Italy. [Becciolini A] Department of Medicine, Internal Medicine and Rheumatology Unit, Azienda Ospedaliero, Universitaria di Parma, Parma, Italy. [Camarda F] Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology Section, University of Palermo, Palermo, Italy. [Cauli A] Rheumatology Unit, University Clinic AOU Cagliari, Monserrato CA, Italy. [Cazenave T] Institute of Psychophysical Rehabilitation (IREP), Buenos Aires, Argentina. [de Agustin de Oro JJ, Michelena X] Servei de Reumatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
| dc.identifier.pmid | 40913840 |
| dc.identifier.wos | 001569285800001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |